DePuy Synthes receives FDA 510(k) clearance of MIS lumbar interbody fusion platform
DePuy Synthes has announced FDA 510(k) clearance of the Teligen system, a platform of digital tools for minimally invasive transforaminal lumbar interbody fusion procedures, according to a company press release.
The Teligen platform is designed to offer surgeons enhanced visualization, access and control for minimally invasive surgical transforaminal lumbar interbody fusion (MIS-TLIF) procedures. The system is comprised of a high-definition disposable camera control system, a discectomy device and patient-based disposable ports, according to the release.

“Improving the MIS spinal surgery experience for both patients and surgeons is a critical step to addressing unmet needs in the industry,” Russell Powers, worldwide president of spine at DePuy Synthes, said in the release. “With our groundbreaking Teligen technology platform, we're providing a better field of view to help improve patient care and increase efficiencies.”